Glucose-insulin-potassium revived: current status in acute coronary syndromes and the energy-depleted heart.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Circulation

• Publication date

  2013-03-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.112.130625PMID 23459576
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial.

  2012cited by this paper
• Ventricular Assist Device Implantation Corrects Myocardial Lipotoxicity, Reverses Insulin Resistance, and Normalizes Cardiac Metabolism in Patients With Advanced Heart Failure

  2012influential reference
• Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury.

  2012cited by this paper
• Chronic heart failure: a reversible metabolic syndrome?

  2012cited by this paper
• Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart.

  2011cited by this paper
• The Role of Uncoupling Protein 2 in the Apoptosis Induced by Free Fatty Acid in Rat Cardiomyocytes

  2010cited by this paper
• Comparison of glucose-insulin-potassium and insulin-glucose as adjunctive therapy in acute myocardial infarction: a contemporary meta-analysis of randomised controlled trials

  2010cited by this paper
• Lipotoxicity in the heart.

  2010influential reference
• Myocardial fatty acid metabolism in health and disease.

  2010influential reference
• Myocardial Steatosis and Biventricular Strain and Strain Rate Imaging in Patients With Type 2 Diabetes Mellitus

  2010cited by this paper
• Significance of an index of insulin resistance in non-diabetic patients with impaired fasting glucose with acute myocardial infarction and its correlation to short term outcome.

  2009cited by this paper
• The adrenergic-fatty acid load in heart failure.

  2009cited by this paper
• Free fatty acid-induced muscle insulin resistance and glucose uptake dysfunction: evidence for PKC activation and oxidative stress-activated signaling pathways.

  2009cited by this paper
• Reperfusion Injury, Microvascular Dysfunction, and Cardioprotection: The “Dark Side” of Reperfusion

  2009cited by this paper
• Metabolic Management of Acute Myocardial Infarction Comes to the Fore and Extends Beyond Control of Hyperglycemia

  2008cited by this paper
• Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006.

  2008cited by this paper
• Glucose-insulin-potassium for acute myocardial infarction: continuing controversy over cardioprotection.

  2008influential reference
• Ion transport and energetics during cell death and protection.

  2008cited by this paper
• The malonyl CoA axis as a potential target for treating ischaemic heart disease.

  2008cited by this paper
• Trimetazidine, a Metabolic Modulator, Has Cardiac and Extracardiac Benefits in Idiopathic Dilated Cardiomyopathy

  2008cited by this paper
• Free fatty acids act as endogenous ionophores, resulting in Na+ and Ca2+ influx and myocyte apoptosis.

  2008cited by this paper
• Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus.

  2008cited by this paper
• Different effects of palmitoyl-L-carnitine and palmitoyl-CoA on mitochondrial function in rat ventricular myocytes.

  2008cited by this paper
• Metabolic mechanisms in heart failure.

  2007cited by this paper
• Effect of modified glucose-insulin-potassium on free fatty acids, matrix metalloproteinase, and myoglobin in ST-elevation myocardial infarction.

  2007cited by this paper
• Effect of glucose-insulin-potassium (GIK) infusion on biomarkers of cardiovascular risk in ST elevation myocardial infarction (STEMI): insight into the failure of GIK

  2007cited by this paper
• The regulation of ion channels and transporters by glycolytically derived ATP

  2007cited by this paper
• Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction.

  2006cited by this paper
• Effects of glucose-insulin-potassium infusion on myocardial perfusion and left ventricular remodeling in patients treated with primary angioplasty for ST-elevation acute myocardial infarction.

  2006cited by this paper
• Effect of Glucose-Insulin-Potassium Infusion on Mortality in Patients With Acute ST-Segment Elevation Myocardial Infarction: The CREATEECLA Randomized Controlled Trial

  2006cited by this paper
• Glucose-insulin-potassium infusion in patients with acute myocardial infarction without signs of heart failure: the Glucose-Insulin-Potassium Study (GIPS)-II.

  2006cited by this paper
• Contribution of Protons to Post‐Ischemic Na+ and Ca2+ Overload and Left Ventricular Mechanical Dysfunction

  2006cited by this paper
• Physiologically Tolerable Insulin Reduces Myocardial Injury and Improves Cardiac Functional Recovery in Myocardial Ischemic/Reperfused Dogs

  2006cited by this paper
• Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death Published, JLR Papers in Press, September 7, 2006.

  2006cited by this paper
• Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.

  2005cited by this paper
• Effects of glucose-insulin-potassium infusion on ST-elevation myocardial infarction in patients treated with thrombolytic therapy.

  2005cited by this paper
• A challenge to the metabolic approach to myocardial ischaemia.

  2005cited by this paper
• Effect of glucose-insulin-potassium infusion on myocardial damage due to percutaneous coronary revascularization.

  2005cited by this paper
• Reversal of Glucose-Insulin-Potassium-Induced Hyperglycemia by Aggressive Insulin Treatment in Postoperative Heart Failure

  2004cited by this paper
• Effects of fatty acids in isolated mitochondria: implications for ischemic injury and cardioprotection.

  2003cited by this paper
• Effects of glucose–insulin–potassium infusion on chronic ischaemic left ventricular dysfunction

  2003cited by this paper
• Heart Physiology: From Cell to Circulation

  2003cited by this paper
• Long-term glucose insulin potassium infusion improves systolic and diastolic function in patients with chronic ischemic cardiomyopathy.

  2003cited by this paper
• High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post-ischemic hearts by inhibiting glucose oxidation.

  2002cited by this paper
• Glucose, insulin and potassium (GIK) during reperfusion mediates improved myocardial bioenergetics.

  2002cited by this paper
• Cardiac-Specific Overexpression of GLUT1 Prevents the Development of Heart Failure Attributable to Pressure Overload in Mice

  2002cited by this paper
• Increased glycolysis during ischaemia mediates the protective effect of glucose and insulin in the isolated rat heart despite the presence of cardiodepressant exogenous substrates.

  2002cited by this paper
• Glucose insulin potassium infusion improves systolic function in patients with chronic ischemic cardiomyopathy

  2002cited by this paper
• Myocardial Free Fatty Acid and Glucose Use After Carvedilol Treatment in Patients With Congestive Heart Failure

  2001cited by this paper
• Glucose-Insulin-Potassium Reduces Infarct Size When Administered During Reperfusion

  2000cited by this paper
• A metabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis.

  2000cited by this paper
• Myocardial substrate metabolism influences left ventricular energetics in vivo.

  2000cited by this paper
• ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate.

  2000cited by this paper
• Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group.

  1998cited by this paper
• Metabolic Modulation of Acute Myocardial Infarction The ECLA Glucose-Insulin-Potassium Pilot Trial

  1998cited by this paper
• Glucose and glycogen utilisation in myocardial ischemia - changes in metabolism and consequences for the myocyte

  1998influential reference
• Alterations in fatty acid oxidation during reperfusion of the heart after myocardial ischemia.

  1997cited by this paper
• Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials.

  1997cited by this paper
• Case-control study of sudden infant death syndrome in Scotland, 1992-5

  1997cited by this paper
• Substrate metabolism as a determinant for postischemic functional recovery of the heart.

  1997cited by this paper
• Increases in serum unbound free fatty acid levels following coronary angioplasty.

  1996cited by this paper
• Coronary flow and glucose delivery as determinants of contracture in the ischemic myocardium.

  1995cited by this paper
• Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year.

  1995cited by this paper
• Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery after reperfusion.

  1994cited by this paper
• In vivo regulation of lipolysis in humans.

  1994cited by this paper
• Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias.

  1994cited by this paper
• The functional recovery of post-ischemic myocardium requires glycolysis during early reperfusion.

  1993cited by this paper
• An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts.

  1993cited by this paper
• Relation between glycolysis and calcium homeostasis in postischemic myocardium.

  1992cited by this paper
• Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions.

  1991cited by this paper
• The cell biology of acute myocardial ischemia.

  1991cited by this paper
• Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart.

  1991cited by this paper
• Glucose requirement for postischemic recovery of perfused working heart.

  1990cited by this paper
• Effects of preoperative glucose-insulin-potassium on myocardial glycogen levels and on complications of mitral valve replacement.

  1986cited by this paper
• Plasma glucose on admission to hospital as a metabolic index of the severity of acute myocardial infarction.

  1986cited by this paper
• Plasma glucose on admission to hospital as a metabolic index of the severity of acute myocardial infarction.

  1986cited by this paper
• Amphipathic metabolites and membrane dysfunction in ischemic myocardium.

  1984cited by this paper
• Relation between plasma free fatty acids and arrhythmias within the first twelve hours of acute myocardial infarction.

  1983cited by this paper
• Determinants of a protective effect of glucose and insulin on the ischemic myocardium. Effects on contractile function, diastolic compliance, metabolism, and ultrastructure during ischemia and reperfusion.

  1983cited by this paper
• A flow- and time-dependent index of ischemic injury after experimental coronary occlusion and reperfusion.

  1983cited by this paper
• Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction.

  1981cited by this paper
• Surgical management of acute and chronic cardiac mechanical complications due to myocardial infarction.

  1981cited by this paper
• Clinical effects of glucose-insulin-potassium on left ventricular function in acute myocardial infarction: results from a randomized clinical trial.

  1981cited by this paper
• Glucose-insulin-potassium induced alterations in individual plasma free fatty acids in patients with acute myocardial infarction.

  1981cited by this paper
• Effect of glucose-insulin-potassium infusions on epicardial ECG changes and on myocardial metabolic changes after coronary artery ligation in dogs.

  1981cited by this paper
• Effects of Substrates on Tissue Metabolic Changes in the Isolated Rat Heart during Underperfusion and on Release of Lactate Dehydrogenase and Arrhythmias during Reperfusion

  1978cited by this paper
• Proposed metabolic vicious circle in patients with large myocardial infarcts and high plasma-free-fatty-acid concentrations.

  1977cited by this paper
• Effects of glucose-insulin-potassium on myocardial substrate availability and utilization in stable coronary artery disease. Studies on myocardial carbohydrate, lipid and oxygen arterial-coronary sinus differences in patients with coronary artery disease.

  1975cited by this paper
• Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Relation to myocardial ischemia and infarct size.

  1975influential reference
• Effects of Glucose, Insulin and Potassium Infusion on Tissue Metabolic Changes Within First Hour of Myocardial Infarction in the Baboon

  1975cited by this paper
• The effect of glucose-insulin-potassium on cardiac ultrastructure following acute experimental coronary occlusion.

  1973cited by this paper
• Effect of Glucose‐Insulin‐Potassium Infusion on Myocardial Infarction following Experimental Coronary Artery Occlusion

  1972cited by this paper
• Effect of free fatty acids on myocardial function and metabolism in the ischemic dog heart.

  1972cited by this paper
• Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs.

  1971cited by this paper
• Insulin and the heart.

  1971cited by this paper
• A metabolic cause for arrhythmias during acute myocardial hypoxia.

  1970cited by this paper
• INSULIN AND THE HEART

  1970cited by this paper
• Increased plasma-free-fatty-acid concentrations and their significance in patients with acute myocardial infarction.

  1969cited by this paper
• The coronary care unit. New perspectives and directions.

  1967cited by this paper
• Serum-free-fatty-acids after acute myocardial infarction and cerebral vascular occlusion.

  1966cited by this paper

• ATGL From iWAT and BAT Is Crucial for Cardiac Remodeling and Metabolism After Myocardial Ischemia/Reperfusion

  2026cites this paper
• Emerging therapy strategies for energy metabolism in acute myocardial infarction

  2025cites this paper
• Role of glycogen in cardiac metabolic stress.

  2024cites this paper
• Effect of glucose-insulin-potassium on lactate levels at the end of surgery in patients undergoing cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: study protocol for a randomized controlled trial

  2024cites this paper
• The Lure of Cardiac Metabolism in the Diagnosis, Prevention, and Treatment of Heart Failure.

  2023cites this paper
• Reduced Left Ventricular Function on Cardiac MRI in SLE Patients Correlates with Measures of SLE Disease Activity and Inflammation

  2023cites this paper
• Reduced left ventricular function on cardiac MRI of SLE patients correlates with measures of disease activity and inflammation

  2023cites this paper
• An Opportune Time to Consider Glucose–Insulin–Potassium Therapy for Takotsubo Syndrome

  2023cites this paper
• Cardiac muscle physiology

  2023cites this paper
• Myocardial protection with glucose-insulin potassium in patients with acute coronary syndromes requiring coronary artery bypass grafting: A case series

  2022cites this paper
• Glucose-Insulin-Potassium Therapy for Acute Myocardial Infarction: 50 Years On and Time for a Relook.

  2022cites this paper
• Management of Acute Aluminum Phosphide Poisoning: Has Anything Changed?

  2021cites this paper
• Targeting myocardial ischaemic injury in the absence of reperfusion

  2020cites this paper
• Aberrant cardiac metabolism leads to cardiac arrhythmia.

  2020cites this paper
• Low Insulin Is an Independent Predictor of All‐Cause and Cardiovascular Death in Acute Decompensated Heart Failure Patients Without Diabetes Mellitus

  2020cites this paper
• Modified Glucose‐Insulin‐Potassium Regimen Provides Cardioprotection With Improved Tissue Perfusion in Patients Undergoing Cardiopulmonary Bypass Surgery

  2020cites this paper
• The acute coronary syndrome revisited: effects and therapeutic modulation of excess metabolic fuel supply.

  2020cites this paper
• Synthesis and Cardiotropic Activity of Linear Methoxyphenyltriazaalkanes

  2019cites this paper
• Editor’s Choice- Pathophysiology and therapy of myocardial ischaemia/reperfusion syndrome

  2019cites this paper
• Prolonged Cold Ischemia Time in Mouse Heart Transplantation Using Supercooling Preservation

  2019cites this paper
• Pretreatment with glucose–insulin–potassium improves ventricular performances after coronary artery bypass surgery: a randomized controlled trial

  2019cites this paper
• Modulation of Serum Adropin Levels by Isoproterenol-Induced Acute Myocardial Infarction in Normal and Obese Male Albino Rats

  2019influential citation
• Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target

  2018cites this paper
• EFFICACY-TO-EFFECTIVENESS CLINICAL TRIALS.

  2018cites this paper
• Dietary fat is a key determinant in balancing mitochondrial dynamics in heart failure: a novel mechanism underlying the obesity paradox.

  2018cites this paper
• Preoperative serum potassium predicts the clinical outcome after non-cardiac surgery

  2017cites this paper
• Changing the incentives for development of low-cost high-impact treatments

  2017cites this paper
• One‐Year Outcome of Intensive Insulin Therapy Combined to Glucose‐Insulin‐Potassium in Acute Coronary Syndrome: A Randomized Controlled Study

  2017cites this paper
• Biochemical markers of type 2 diabetes as a late complication of myocardial infarction: a case-control study

  2017cites this paper
• Possible increase in insulin resistance and concealed glucose-coupled potassium-lowering mechanisms during acute coronary syndrome documented by covariance structure analysis

  2017cites this paper
• Modulation of myocardial energetics: An important category of agents in the multimodal treatment of coronary artery disease and heart failure

  2017cites this paper
• Imaging porcine cardiac substrate selection modulations by glucose, insulin and potassium intervention: A hyperpolarized [1‐13C]pyruvate study

  2017cites this paper
• Metabolic Origins of Heart Failure

  2017cites this paper
• The role of PI3Kα in cardioprotection

  2017cites this paper
• Insulin Postconditioning Reduces Infarct Size in the Porcine Heart in a Dose-Dependent Manner

  2017cites this paper
• A critical review on the translational journey of cardioprotective therapies!

  2016cites this paper
• Very early administration of glucose-insulin-potassium by emergency medical service for acute coronary syndromes: Biological mechanisms for benefit in the IMMEDIATE Trial.

  2016cites this paper
• MyoK+ardial Infarction

  2016cites this paper
• Causes and mechanisms of an adverse outcome in patients with glucose abnormalities and cardiovascular disease : epidemiological and biochemical analyses

  2016cites this paper
• Role of Mammalian Target of Rapamycin (mTOR) in Cardiac Homeostasis in Metabolic Disorders

  2016cites this paper
• Glycaemic control for patients with acute coronary syndrome

  2016cites this paper
• C-Reactive protein reactions to glucose-insulin-potassium infusion and relations to infarct size in patients with acute coronary syndromes

  2015cites this paper
• Glucose-Insulin-Potassium Solution Protects Ventricular Myocytes of Neonatal Rat in an In Vitro Coverslip Ischemia/Reperfusion Model

  2015cites this paper
• Genetic modifiers of response to glucose–insulin–potassium (GIK) infusion in acute coronary syndromes and associations with clinical outcomes in the IMMEDIATE trial

  2015cites this paper
• Insulin prevents bone morphogenetic protein-4 induced cardiomyocyte apoptosis through activating Akt.

  2015cites this paper
• Intracoronary insulin administered at reperfusion in a porcine model of acute coronary syndrome

  2015cites this paper
• Will be the insulin a possible treatment for a acute myocardial ischemia

  2015cites this paper
• Elevated adropin: a candidate diagnostic marker for myocardial infarction in conjunction with troponin-I.

  2014cites this paper
• One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care] Trial).

  2014cites this paper
• The role of melatonin in cardioprotection : an investigation into the mechanisms involved in glucose homeostasis, microvascular endothelial function and mitochondrial function in normal and insulin resistant states

  2014cites this paper
• Cardiac Metabolism in Health and Disease

  2014cites this paper
• Testing metabolic and pharmacological agents for recovery following de novo acute heart failure in an isolated rat heart model

  2014cites this paper
• ST elevation myocardial infarction: recent advances and updates.

  2014cites this paper
• The Gut Hormone Ghrelin Partially Reverses Energy Substrate Metabolic Alterations in the Failing Heart

  2014cites this paper
• Glucose–insulin–potassium therapy in patients with acute coronary syndrome: a meta-analysis of randomized controlled trials

  2014influential citation
• Unbound Free Fatty Acids from Preterm Infants Treated with Intralipid Decouples Unbound from Total Bilirubin Potentially Making Phototherapy Ineffective

  2014cites this paper
• Genetic variation at glucose and insulin trait loci and response to glucose–insulin–potassium (GIK) therapy: the IMMEDIATE trial

  2014cites this paper
• Management of acute myocardial infarction.

  2014cites this paper
• The heart is better protected against myocardial infarction in the fed state compared to the fasted state.

  2014cites this paper
• Usefulness of serum unbound free fatty acid levels to predict death early in patients with ST-segment elevation myocardial infarction (from the Thrombolysis In Myocardial Infarction [TIMI] II trial).

  2014cites this paper
• Usefulness of Serum Unbound Free Fatty Acid Levels to Predict Death Early in Patients with ST Segment Elevation Myocardial Infarction[From the TIMI II Trial]

  2014cites this paper
• A community consultation survey to evaluate support for and success of the IMMEDIATE trial

  2014cites this paper
• Insulin regulation of myocardial autophagy.

  2014cites this paper
• Mitochondrially targeted nitro‐linoleate: a new tool for the study of cardioprotection

  2014influential citation
• Energy metabolic changes in the diabetic heart

  2013cites this paper
• Unbound Free Fatty Acids from Preterm Infants Treated with Intralipid Decouples Unbound from Total Bilirubin Potentially Making Phototherapy Ineffective

  2013cites this paper
• Cardioprotection against myocardial reperfusion injury: successes, failures, and perspectives.

  2013cites this paper
• Bibliography çEditors ’ selectionof current world literature

  2013cites this paper
• Atherosclerotic Coronary Artery Disease

  2013cites this paper
• Trials, tribulations and speculation! Report from the 7th Biennial Hatter Cardiovascular Institute Workshop

  2012cites this paper